HPV Infection Clinical Trials

30 recruiting

HPV Infection Trials at a Glance

33 actively recruiting trials for hpv infection are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Mayfield Heights, Mianyang, and Cleveland. Lead sponsors running hpv infection studies include Shanghai Bovax Biotechnology Co., Ltd., Frantz Viral Therapeutics, LLC, and Centre Hospitalier Universitaire de la Réunion.

Browse hpv infection trials by phase

Treatments under study

About HPV Infection Clinical Trials

Looking for clinical trials for HPV Infection? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HPV Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HPV Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Not Applicable

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

HIV InfectionsCervix CancerHPV Infection
UNC Lineberger Comprehensive Cancer Center2,912 enrolled1 locationNCT07428330
Recruiting
Not Applicable

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

Cervical CancerHPV Infection
Washington University School of Medicine100 enrolled1 locationNCT07453459
Recruiting
Phase 4

Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection

Persistent HR-HPV Infection of the Cervix
The First Hospital of Jilin University115 enrolled1 locationNCT07493824
Recruiting
Not Applicable

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

Cervical CancerHIV InfectionsHPV Infection
Columbia University600 enrolled1 locationNCT07225530
Recruiting
Not Applicable

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

HPV InfectionHPV 16 Infection
Qurasense450 enrolled4 locationsNCT07281599
Recruiting

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

Cervical CancerHPV Infection
University Hospital Tuebingen50 enrolled1 locationNCT06291311
Recruiting
Not Applicable

Pocket Colposcopy Using CARE Algorithm

Cervical CancerHPV Infection
Duke University1,079 enrolled1 locationNCT06458062
Recruiting
Phase 2

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

HPV-Related CarcinomaHPV InfectionGenital Wart+1 more
Shanghai Bovax Biotechnology Co., Ltd.330 enrolled1 locationNCT06756269
Recruiting
Phase 4

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

HPV Infection
Zhejiang Provincial Center for Disease Control and Prevention400 enrolled1 locationNCT07281677
Recruiting
Not Applicable

Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV

HPV Infection
Centre Hospitalier Universitaire de la Réunion398 enrolled2 locationsNCT06507917
Recruiting
Not Applicable

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Anal CancerHPV Infection
ANRS, Emerging Infectious Diseases100 enrolled3 locationsNCT06522256
Recruiting
Not Applicable

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

HPV Infection
Lo.Li.Pharma s.r.l100 enrolled1 locationNCT06285357
Recruiting
Phase 4

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Human PapillomavirusHPV InfectionImmunization
The University of Texas Medical Branch, Galveston618 enrolled1 locationNCT05672927
Recruiting
Phase 2

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

HPV InfectionCervical DysplasiaCIN 2/3+2 more
Frantz Viral Therapeutics, LLC78 enrolled7 locationsNCT04098744
Recruiting

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Uterine Cervical NeoplasmsHPV InfectionHIV I Infection
University of Bern250 enrolled1 locationNCT07202936
Recruiting

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

HPV InfectionDysplasia AnusOral Cavity Disease
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau384 enrolled1 locationNCT05911750
Recruiting
Phase 2

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Vulvar DiseasesHPV InfectionHigh Grade Intraepithelial Neoplasia+10 more
Frantz Viral Therapeutics, LLC27 enrolled5 locationsNCT06075264
Recruiting

Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

HIV InfectionsHPV-Related MalignancyHPV Infection
University of California, San Francisco135 enrolled1 locationNCT07087145
Recruiting
Not Applicable

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

HPV-Related CarcinomaHPV Infection
PCK Marine Hospital in Gdynia248 enrolled1 locationNCT06574087
Recruiting

Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

HPV Infection
International Vaccine Institute29,750 enrolled8 locationsNCT06129253